Trial Profile
Evaluating the Plasma Pharmacokinetics of CRD-102 in patients with Heart Failure following long term administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jan 2018
Price :
$35
*
At a glance
- Drugs CRD 102 (Primary)
- Indications Heart failure
- Focus Pharmacokinetics
- Sponsors Cardiora
- 22 Jan 2018 Status changed from not yet recruiting to completed.
- 01 Jul 2016 New trial record